Cart is empty More than 90% of postmenopausal women were never taught about menopause at school and more than 60% only started looking for information about it once their symptoms had started, finds a new UCL-led study.
Study shows young adults don’t easily transition to self-care of diabetes
Diabetes is challenging to manage at any age, but even more so for young adults who are handling the condition on their own for the first time. They need to transition from pediatric to adult care as smoothly as possible—but a recent study finds this isn’t happening.
Have a second cup: Coffee provides health benefits, says study
Having that second cup may actually be good for coffee drinkers, according to a discussion of coffee’s preventive and therapeutic benefits to human health in a recent review paper by Texas A&M University researchers.
Research identifies potential to improve lung cancer survival rates through therapy choices
While Immune Checkpoint Inhibitor (ICI) immunotherapy drugs have transformed the treatment of many cancers, some lung cancer patients experience hyperprogression—a paradoxical rapid acceleration of tumor growth—after the treatment begins.
Study: Living in disadvantaged neighborhood shortens breast cancer survival
Breast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 in JAMA Network Open.
Suicide link to climate change unfounded, says researcher
A James Cook University researcher says there is no evidence climate change is associated with increased suicide rates, and health administrators who believe there is may be prioritizing a carbon net zero policy over patient health. The paper is published in the journal Australasian Psychiatry.
Dutch court orders semen donor to stop after 550 children
Dutch judges on Friday ordered a man suspected of fathering more than 550 children through sperm donations to stop donating, in the latest fertility scandal to shock the Netherlands.
Making ionocytes: A step toward cell or gene therapy for cystic fibrosis
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators were a breakthrough for cystic fibrosis, improving the movement of chloride and water and moistening mucus secretions. But these drugs are expensive, don’t work in all patients with cystic fibrosis, and have side effects and interactions with other drugs. People who do respond to CFTR modulators must take them for a lifetime.
Bold new therapy delivery method shows initial promise as treatment for Duchenne muscular dystrophy
Doug Millay, Ph.D., a scientist with the Division of Molecular Cardiovascular Biology at Cincinnati Children’s has dedicated his career to revealing the most fundamental mechanisms of skeletal muscle development. He has been a leader in characterizing how two “fusogens” called Myomaker and Myomerger mediate the entry of stem cells into mature muscle cells to build the tissue that humans depend upon for movement, breathing, and survival.
Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment
The patient-reported outcomes (PROs) of the phase 3 NRG Oncology clinical trial RTOG 0815 comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT combined with short-term (6 months) androgen deprivation therapy (STAD) indicate that the addition of STAD did not significantly impact urinary or bowel quality of life but did significantly decrease hormone and sexual quality of life. However, this decline in quality of life was temporary and there were no clinically meaningful differences in quality of life between treatment arms by one year after the initiation of treatment. These results of this study, led by Benjamin Movsas, were recently published in the Journal of Clinical Oncology.